[1] Huang G, Li RJ, Bai Q, et al. Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review[J]. Health Inf Sci Syst, 2023, 11(1): 32-44.
[2] 郭衷钊, 李颖, 卢钰, 等. 阿尔茨海默病慢性疼痛的影响因素及中医病机探究[J]. 中西医结合心脑血管病杂志, 2023, 21(14): 2622-2625.
[3] 关徐涛, 关运祥, 张振强. 阿尔茨海默病中医核心病机演变规律[J]. 中医学报, 2022, 37(6): 1153-1157.
[4] 郭佳越, 汤燚, 杨银, 等. 阿尔茨海默病的病因与发病机制研究进展[J]. 中国医药导报, 2024, 21(1): 39-42.
[5] 田洪伦, 罗洁, 韩小娟, 等. 阿尔茨海默病患者Hcy、FOL、Vit B-(12)水平与ApoE基因多态性研究[J]. 中外医学研究, 2023, 21(18): 162-166.
[6] 王荣, 陈帅, 赵彩丽, 等. 多基因风险评分与机器学习建模策略下轻度认知障碍发展为阿尔茨海默病的预后研究[J]. 中华疾病控制杂志, 2023, 27(6): 684-690.
[7] Giulio P, Simona L, Matteo M, et al. Vasoactive neuropeptides and Alzheimer's disease: a systematic review focusing on calcitonin gene-related peptide[J]. J Integr Neurosci, 2021, 20(4): 1059-1065.
[8] Diwakar L, Gowaikar R, Chithanathan K, et al. Endothelin-1 mediated vasoconstriction leads to memory impairment and synaptic dysfunction[J]. Scientific Reports, 2021, 11: 4868-4880.
[9] Orhan TK, Hakan A, Nurgul A, et al. Vasoactive intestinal peptide decreases β-amyloid accumulation and prevents brain atrophy in the 5xFAD mouse model of Alzheimer's Disease[J]. J Mol Neurosci, 2019, 68(3): 389-396.
[10] Zala S, Rawien AB, Ronald WH, et al. VerwerAlterations in pituitary adenylate cyclase-activating polypeptide in major depressive disorder,bipolar disorder, and comorbid depression in Alzheimer's disease in the human hypothalamus and prefrontal cortex[J]. Psychol Med, 2023, 53(16): 7537-7549.
[11] Stephanie P, Sebastien B, Afsaneh G. Neuroprotective effects of neuropeptide Y against neurodegenerative disease[J]. Curr Neuropharmacol, 2022, 20(9): 1717-1725.
[12] Cinzia S, Carla P, Pietro C. Substance P and Alzheimer's disease:emerging novel roles[J]. Curr Alzheimer Res, 2016, 13(9): 964-972.
[13] Shiran S, Thomas JE, David LB. Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology[J]. PLoS One, 2022, 17(10): e0276107.
[14] Gao WR, Hu XH, Yu KY, et al. Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice[J]. Behav Brain Res, 2023, 438: 114171.
[15] 范红娟, 康凯宁, 栗志英. 芹菜素对Aβ-(1-42)致阿尔茨海默病大鼠海马组织氧化应激和炎症反应的影响[J]. 中医学报, 2023, 38(3): 602-608.
[16] 周冰凌, 邵卫, 邱昕, 等. 微核糖核酸-125a通过调控细胞凋亡和炎症反应延缓阿尔茨海默病进展的研究[J]. 上海医学, 2023, 46(1): 17-22.
[17] 邓天玲, 段爱琴, 曾敏玲, 等. 血清miR-340-5p和APPL1水平与老年阿尔茨海默病患者炎症反应与认知功能的相关性[J]. 热带医学杂志, 2022, 22(11): 1551-1556.
[18] 谢平安, 廖辉, 张艳敏, 等. miR-146a尾静脉注射对阿尔茨海默病大鼠认知能力、Th17/Treg分布及炎症因子水平的影响[J]. 山东医药, 2022, 62(20): 46-49.
[19] Wang YB, Liu XX. The Effective components, core targets,and key pathways of ginseng against Alzheimer's Disease[J]. Evid Based Complement Alternat Med, 2023, 2023: 9935942-9935954.
[20] Cristina S, Loretta G, Paola C, et al. Sex, age, and regional differences in CHRM1 and CHRM3 genes expression levels in the human brain biopsies:potential targets for Alzheimer's disease-related sleep disturbances[J]. Curr Neuropharmacol, 2023, 21(3): 740-760.
[21] Cheng XF, Yang QF, Liu J. Constitutional 763.3 Kb chromosome 1q43 duplication encompassing only CHRM3 gene identified by next generation sequencing (NGS) in a child with intellectual disability[J]. Mol Cytogenet, 2019, 12: 16-22.
[22] Aafke E, Barbara F, Ouden AL, et al. The phenotypic spectrum of proximal 6q deletions based on a large cohort derived from social media and literature reports[J]. Eur J Hum Genet, 2018, 26(10): 1478-1489.
[23] 夏皙. HTR1B基因调控区与精神分裂症的相关性及法医学意义[D]. 沈阳: 中国医科大学, 2020.
[24] Tsai RT, Tsai CW, Liu SP, et al. Maackiain ameliorates 6-Hydroxydopamine and SNCA pathologies by modulating the PINK1/Parkin pathway in models of Parkinson's Disease in caenorhabditis elegans and the SH-SY5Y cell line[J]. Int J Mol Sci, 2020, 21(12): 4455-4488.
[25] 王星烨, 孔祥日, 金梦丽, 等. β-谷甾醇对阿尔茨海默病模型小鼠认知功能的改善作用及其机制[J]. 吉林大学学报(医学版), 2023, 49(3): 599-607.
[26] 汪妍言, 黎雪梅. 老年抑郁症与自杀的遗传学研究进展[J]. 实用老年医学, 2023, 37(6): 541-543.
[27] Sabrina B, Dong YJ, Nikola F, et al. Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: a multicenter retrospective study[J]. World J Gastroenterol, 2022, 28(21): 2334-2349.
[28] Li JQ, Zheng SH, Dong YH, et al. Histone methyltransferase SETDB1 regulates the development of cortical htr3a-positive interneurons and mood behaviors[J]. Biol Psychiatry, 2023, 93(3): 279-290.
[29] Huang L, Wang J, Liang GM, et al. Upregulated NMDAR-mediated GABAergic transmission underlies autistic-like deficits in Htr3a knockout mice[J]. Theranostics, 2021, 11(19): 9296-9310.
[30] Zhou H, Wang KX, Xu ZC, et al. Chronic unpredictable stress induces depression/anxiety-related behaviors and alterations of hippocampal monoamine receptor mRNA expression in female mice at different ages[J]. Heliyon, 2023, 9(7): e18369.
[31] Bi WK, Luan SS, Wang J, et al. FSH signaling is involved in affective disorders[J]. Biochem Biophys Res Commun, 2020, 525(4): 915-920.
[32] Liu LF, Liu YT, Wu DD, et al. Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer's disease[J]. Neural Regen Res, 2023, 18(9): 2019-2028.
[33] Wang PW, Mao SL, Yi TT, et al. LncRNA MALAT1 targets mir-9-3p to upregulate SAP97 in the hippocampus of mice with vascular dementia[J]. Biochem Genet, 2023, 61(3): 916-930.
